Appropriate Scaffold Selection for CNS Tissue Engineering
- PMID: 33014312
- PMCID: PMC7502166
Appropriate Scaffold Selection for CNS Tissue Engineering
Abstract
Cellular transplantation, due to the low regenerative capacity of the Central Nervous System (CNS), is one of the promising strategies in the treatment of neurodegenerative diseases. The design and application of scaffolds mimicking the CNS extracellular matrix features (biochemical, bioelectrical, and biomechanical), which affect the cellular fate, are important to achieve proper efficiency in cell survival, proliferation, and differentiation as well as integration with the surrounding tissue. Different studies on natural materials demonstrated that hydrogels made from natural materials mimic the extracellular matrix and supply microenvironment for cell adhesion and proliferation. The design and development of cellular microstructures suitable for neural tissue engineering purposes require a comprehensive knowledge of neuroscience, cell biology, nanotechnology, polymers, mechanobiology, and biochemistry. In this review, an attempt was made to investigate this multidisciplinary field and its multifactorial effects on the CNS microenvironment. Many strategies have been used to simulate extrinsic cues, which can improve cellular behavior toward neural lineage. In this study, parallel and align, soft and injectable, conductive, and bioprinting scaffolds were reviewed which have indicated some successes in the field. Among different systems, three-Dimensional (3D) bioprinting is a powerful, highly modifiable, and highly precise strategy, which has a high architectural similarity to tissue structure and is able to construct controllable tissue models. 3D bioprinting scaffolds induce cell attachment, proliferation, and differentiation and promote the diffusion of nutrients. This method provides exceptional versatility in cell positioning that is very suitable for the complex Extracellular Matrix (ECM) of the nervous system.
Keywords: Bioprinting; Cell differentiation; Extracellular matrix; Neurodegenerative diseases; Tissue engineering.
Copyright© 2020 Avicenna Research Institute.
Figures
References
-
- Johnson GS. Commercial viability of CNS drugs: Balancing the risk/reward profile. Neurobiol Dis 2014; 61: 21– 24. - PubMed
-
- Brunner D, Balcı F, Ludvig EA. Comparative psychology and the grand challenge of drug discovery in psychiatry and neurodegeneration. Behav Processes 2012; 89( 2): 187– 195. - PubMed
-
- Li X, Katsanevakisa E, Liua X, Zhangab N, Wen X. Engineering neural stem cell fates with hydrogel design for central nervous system regeneration. Prog Polym Sci 2012; 37( 8): 1105– 1129.
Publication types
LinkOut - more resources
Full Text Sources